Akebia Therapeutics (AKBA) EBT Margin Growth (3y) (2020 - 2026)
Akebia Therapeutics (AKBA) EBT Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1,840.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -134.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1,686.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 12,811.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 5,487.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -225.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -15,283.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1,162.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 4,514.00 |
| 10 | Akebia Therapeutics | 243.23 Mn | 80.63 Mn | 41.25 Mn | 5,051.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,051.00 |
| Dec 31, 2025 | -784.00 |
| Sep 30, 2025 | 11,355.00 |
| Jun 30, 2025 | -6,665.00 |
| Mar 31, 2025 | 16,691.00 |
| Dec 31, 2024 | -9,535.00 |
| Sep 30, 2024 | 6,946.00 |
| Jun 30, 2024 | 13,966.00 |
| Mar 31, 2024 | 7,818.00 |
| Dec 31, 2023 | 40,111.00 |
| Sep 30, 2023 | 36,527.00 |
| Jun 30, 2023 | 17,515.00 |
| Mar 31, 2023 | 148.00 |
| Dec 31, 2022 | 32,116.00 |
| Sep 30, 2022 | 44,704.00 |
| Jun 30, 2022 | 14,934.00 |
| Mar 31, 2022 | 16,904.00 |
| Dec 31, 2021 | 134,162.00 |
| Sep 30, 2021 | -7,401.00 |
| Jun 30, 2021 | 61,497.00 |